Scanning for success: can a simple test predict cancer treatment outcomes?
NCT ID NCT07448727
Summary
This study aims to learn if a PET scan taken six weeks after starting immunotherapy can predict how well the treatment will work months later for people with advanced head and neck cancer. Researchers will observe 25 patients receiving standard pembrolizumab treatment and track their scan results. The goal is to gather knowledge that could help doctors make better treatment decisions faster in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD & NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tor Vergata University Hospital
RECRUITINGRome, Italy, 00133, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.